Drug Shortage Report for ELIGARD

Last updated on 2022-05-21 History
Report ID 152360
Drug Identification Number 02248239
Brand name ELIGARD
Common or Proper name Leuprolide acetate for injection
Company Name TOLMAR INTERNATIONAL LTD.
Market Status MARKETED
Active Ingredient(s) LEUPROLIDE ACETATE
Strength(s) 7.5MG
Dosage form(s) POWDER FOR SUSPENSION, EXTENDED-RELEASE
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 Carton / Kit
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-21
Actual start date 2022-01-24
Estimated end date 2022-06-10
Actual end date 2022-05-20
Shortage status Resolved
Updated date 2022-05-21
Company comments ELIGARD® 22.5 mg, 30 mg and 45 mg are available.
Health Canada comments
Tier 3 Status No
Company contact information 1-833-865-6278

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2022-05-21 English Compare
v22 2022-05-20 French Compare
v21 2022-05-20 English Compare
v20 2022-04-20 French Compare
v19 2022-04-20 English Compare
v18 2022-02-15 French Compare
v17 2022-02-15 English Compare
v16 2022-02-15 French Compare
v15 2022-02-15 English Compare
v14 2022-02-01 French Compare
v13 2022-02-01 English Compare
v12 2022-01-24 French Compare
v11 2022-01-24 English Compare
v10 2022-01-24 English Compare
v9 2022-01-22 English Compare
v8 2022-01-07 French Compare
v7 2022-01-07 English Compare
v6 2022-01-07 French Compare
v5 2022-01-07 English Compare
v4 2022-01-07 French Compare

Showing 1 to 20 of 23